Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
Infective Endocarditis
2005 Standout
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
2011 Standout
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures
2002
Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests
2000
Constructing Inverse Probability Weights for Marginal Structural Models
2008 Standout
Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis
1993
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome
2003
Acute Respiratory Failure Associated with Cryptococcosis in Patients with AIDS: Analysis of Predictive Factors
1998
A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Itraconazole Maintenance Treatment for Histoplasmosis in AIDS: A Prospective, Multicenter Trial
1997
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
1995
Incidence and Risk Factors for Toxoplasmic Encephalitis in Human Immunodeficiency Virus–Infected Patients before and during the Highly Active Antiretroviral Therapy Era
2001
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial
1996
Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure
2000
Abdominal Wall Mucormycosis Successfully Treated with Amphotericin and Itraconazole
2002
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
2014
Graphical Tools for Network Meta-Analysis in STATA
2013 Standout
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
1997 Standout
Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients
2000
A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
2017
Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin
1999
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Successful Treatment of Refractory Disseminated Mycobacterium avium Complex Infection with the Addition of Linezolid and Mefloquine
2002
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
2001 Standout
Meta-Analysis of Prophylactic Treatments Against Pneumocystis carinii Pneumonia and Toxoplasma Encephalitis in HIV-Infected Patients
1997
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Preventing Bacterial Respiratory Tract Infections Among Persons Infected with Human Immunodeficiency Virus
1995
Once-Weekly Administration of Dapsone/Pyrimethamine vs. Aerosolized Pentamidine as Combined Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients
1995
Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis
2009
Dapsone-Pyrimethamine Compared with Aerosolized Pentamidine as Primary Prophylaxis against Pneumocystis carinii Pneumonia and Toxoplasmosis in HIV Infection
1993
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Implications for trials in progress of publication of positive results
1993
Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus Infection
1994
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs
2002 Standout
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
2001
Reporting the study populations of clinical trials
2000
Recent Advances in Pulmonary Medicine
1993
Infection in Solid-Organ Transplant Recipients
2007 Standout
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Randomized Study of Sulfamethoxazole-trimethoprim versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with AIDS
1995
How antibiotics kill bacteria: from targets to networks
2010 Standout
Biology of pregnancy‐associated plasma protein‐A in relation to prenatal diagnostics: an overview
2010
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Global land cover mapping from MODIS: algorithms and early results
2002 Standout
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
Prior Elicitation, Variable Selection and Bayesian Computation for Logistic Regression Models
1999
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Prevention of Infection Due toPneumocystisspp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
2004
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
2003 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens
1996
Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimoxazole as prophylaxis against Pneumocystis carinii pneumonia.
1995
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Biological Feedbacks in Global Desertification
1990 StandoutScience
Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
2017
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
The Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in the Elderly
1987
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
Occurrence of Nontuberculous Mycobacteria in Environmental Samples
1999
Prevention of Infection Due toPneumocystis carinii
1998
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Prosthetic Joint Infection
2014 Standout
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
2004
Guidelines for Treatment of Candidiasis
2004 Standout
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
1995 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Works of Maureen Power being referenced
H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
2015
Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
2015
A Randomized, Double‐Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection
1998
One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester
2000
Vancomycin disposition: The importance of age
1984
Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group
1991
A Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
1992
Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group
1991
Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers
1998